Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease

Area of Science:

• Endocrinology
• Cardiovascular Science
• Metabolic Research

Background:

• Insulin resistance is a key factor in metabolic syndrome, contributing to cardiovascular disease via metabolic dysfunction, hypertension, and inflammation.
• Insulin's direct effects on the vasculature, immune cells, and organs are increasingly recognized.

Purpose of the Study:

• To explore the direct impact of impaired insulin signaling on cardiovascular disease progression within the metabolic syndrome.
• To investigate the role of insulin signaling in microvascular complications associated with diabetes mellitus.
• To highlight recent advancements in understanding insulin's vascular effects for potential therapeutic strategies.

Main Methods:

• Review of current literature on insulin signaling pathways.
• Analysis of the direct effects of insulin on endothelial cells, macrophages, heart, kidney, and retina.
• Synthesis of recent findings on the pathophysiology of insulin's vascular actions.

Main Results:

• Impaired insulin signaling directly affects vascular endothelium, plaque macrophages, and key organs, influencing cardiovascular disease progression.
• Dysfunctional insulin signaling in these tissues exacerbates metabolic syndrome-related cardiovascular risks.
• These effects are implicated in the development of microvascular complications in diabetes.

Conclusions:

• Direct insulin actions in vascular tissues are critical in metabolic syndrome and diabetes.
• Understanding these pathways opens new avenues for preventing cardiovascular complications.
• Targeting insulin signaling in specific tissues may offer novel therapeutic approaches.